Deutsche Bank’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-2,702
Closed -$388K 4958
2016
Q4
$388K Hold
2,702
﹤0.01% 3330
2016
Q3
$338K Hold
2,702
﹤0.01% 3382
2016
Q2
$354K Sell
2,702
-800
-23% -$109K ﹤0.01% 3474
2016
Q1
$486K Buy
3,502
+2,809
+405% +$375K ﹤0.01% 3236
2015
Q4
$96K Buy
693
+343
+98% +$47.3K ﹤0.01% 4077
2015
Q3
$49K Hold
350
﹤0.01% 4460
2015
Q2
$57K Sell
350
-650
-65% -$104K ﹤0.01% 4518
2015
Q1
$154K Buy
+1,000
New +$142K ﹤0.01% 3924

Other funds holding ELV

Deutsche Bank's ELV Position: Q1 2026 in Review

Deutsche Bank increased its Elevance Health (ELV) stake by 3.8% in Q1 2026, buying an estimated $11M and bringing the position to 923,423 shares worth $270M. The position accounts for 0.09% of the portfolio, ranked #213.

Deutsche Bank first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $522M in Q4 2022. 1,463 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Deutsche Bank held 923,423 shares of Elevance Health worth $270M as of Q1 2026.
  • Deutsche Bank bought 33,587 Elevance Health shares in Q1 2026, an estimated $11M.
  • Elevance Health made up 0.09% of Deutsche Bank's portfolio in Q1 2026, its #213 holding.
  • Deutsche Bank first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
  • Deutsche Bank's Elevance Health position peaked at $522M in Q4 2022.
  • 1,463 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.